Wells Fargo & Company Vicarious Surgical Inc. Transaction History

Wells Fargo & Company

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.29 - $0.63 $1,405 - $3,053	4,847 Added 16.49%	34,246 $10,000
Q4 2023 Feb 09, 2024	BUY	$0.22 - $0.53 $2,756 - $6,640	12,529 Added 74.27%	29,399 $10,000
Q3 2023 Nov 13, 2023	SELL	$0.59 - $2.04 $6,971 - $24,104	-11,816 Reduced 41.19%	16,870 $9,000
Q2 2023 Aug 15, 2023	BUY	$1.77 - $2.38 $27,997 - $37,646	15,818 Added 122.93%	28,686 $52,000
Q1 2023 May 12, 2023	BUY	$1.5 - $3.5 $19,302 - $45,038	12,868 New	12,868 $29,000
Q3 2022 Nov 14, 2022	SELL	$0.57 - $4.74 $308 - $2,564	-541 Reduced 37.78%	891 $3,000
Q2 2022 Aug 12, 2022	BUY	$2.94 - $5.12 $3,566 - $6,210	1,213 Added 553.88%	1,432 $4,000
Q1 2022 May 16, 2022	BUY	$4.39 - $10.17 $4 - $10	1 Added 0.46%	219 $1,000
Q4 2021 Feb 14, 2022	BUY	$9.89 - $13.83 $2,156 - $3,014	218 New	218 $2,000

1.45M

Ticker RBOT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 102,592,000
Market Cap $592M
Description
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massach...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.